StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Gilead Sciences, Inc.
NasdaqGS:GILD
Sector
Location
Market Cap
USD 134.62 B
Share Price
USD 108.22
Avg Daily Volume
8,937,000
Change (1 day)
-0.53%
Change (1 year)
47.22%
Change (YTD)
17.16%
Gilead Sciences, Inc. Accounts Payable for the year ending December 31, 2024: USD 833.00 M
Gilead Sciences, Inc. Accounts Payable is USD 833.00 M for the year ending December 31, 2024, a 51.45% change year over year. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.
-
Gilead Sciences, Inc. Accounts Payable for the year ending December 31, 2023 was USD 550.00 M, a -39.23% change year over year.
-
Gilead Sciences, Inc. Accounts Payable for the year ending December 31, 2022 was USD 905.00 M, a 28.37% change year over year.
-
Gilead Sciences, Inc. Accounts Payable for the year ending December 31, 2021 was USD 705.00 M, a -16.47% change year over year.
-
Gilead Sciences, Inc. Accounts Payable for the year ending December 31, 2020 was USD 844.00 M, a 18.37% change year over year.
Competitors
AbbVie Inc.
USD 189.26
ABBV
-2.14
-1.12%
Novo Nordisk A/S
USD 64.39
NOVO-B.CO
-1.34
-2.03%
Roche Holding AG
USD 340.88
RO.SW
+2.44
0.72%
Novartis AG
USD 115.07
NOVN.SW
-0.81
-0.70%
AstraZeneca PLC
USD 138.02
AZN.L
-0.31
-0.22%
Abbott Laboratories
USD 123.67
ABT
+3.16
2.62%
Merck & Co., Inc.
USD 79.96
MRK
-1.56
-1.91%
Amgen Inc.
USD 294.76
AMGN
-3.49
-1.17%
Pfizer Inc.
USD 24.47
PFE
-0.11
-0.45%
Vertex Pharmaceuticals Incorporated
USD 459.81
VRTX
-3.46
-0.75%
Sanofi
USD 96.63
SAN.PA
-0.24
-0.24%
Bristol-Myers Squibb Company
USD 47.36
BMY
-0.70
-1.46%
CSL Limited
USD 167.39
CSL.AX
+6.23
3.87%
Chugai Pharmaceutical Co., Ltd.
USD 47.05
4519.T
+0.49
1.05%
GSK plc
USD 18.07
GSK.L
-0.88
-4.65%
Regeneron Pharmaceuticals, Inc.
USD 542.52
REGN
-7.48
-1.36%
MERCK Kommanditgesellschaft auf Aktien
USD 128.57
MRK.DE
-0.77
-0.59%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.18
600276.SS
+0.14
1.80%
Takeda Pharmaceutical Company Limited
USD 29.16
4502.T
-0.53
-1.77%
Alnylam Pharmaceuticals, Inc.
USD 320.53
ALNY
-4.16
-1.28%
Key Data
| Date | Accounts Payable | Short-Term Debt | Long-Term Debt | Total Liabilities |
|---|
Competitors
AbbVie Inc.
USD 189.26
ABBV
-2.14
-1.12%
Novo Nordisk A/S
USD 64.39
NOVO-B.CO
-1.34
-2.03%
Roche Holding AG
USD 340.88
RO.SW
+2.44
0.72%
Novartis AG
USD 115.07
NOVN.SW
-0.81
-0.70%
AstraZeneca PLC
USD 138.02
AZN.L
-0.31
-0.22%
Abbott Laboratories
USD 123.67
ABT
+3.16
2.62%
Merck & Co., Inc.
USD 79.96
MRK
-1.56
-1.91%
Amgen Inc.
USD 294.76
AMGN
-3.49
-1.17%
Pfizer Inc.
USD 24.47
PFE
-0.11
-0.45%
Vertex Pharmaceuticals Incorporated
USD 459.81
VRTX
-3.46
-0.75%
Sanofi
USD 96.63
SAN.PA
-0.24
-0.24%
Bristol-Myers Squibb Company
USD 47.36
BMY
-0.70
-1.46%
CSL Limited
USD 167.39
CSL.AX
+6.23
3.87%
Chugai Pharmaceutical Co., Ltd.
USD 47.05
4519.T
+0.49
1.05%
GSK plc
USD 18.07
GSK.L
-0.88
-4.65%
Regeneron Pharmaceuticals, Inc.
USD 542.52
REGN
-7.48
-1.36%
MERCK Kommanditgesellschaft auf Aktien
USD 128.57
MRK.DE
-0.77
-0.59%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.18
600276.SS
+0.14
1.80%
Takeda Pharmaceutical Company Limited
USD 29.16
4502.T
-0.53
-1.77%
Alnylam Pharmaceuticals, Inc.
USD 320.53
ALNY
-4.16
-1.28%